Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Multisite Osteonecrosis to Long-term Corticoid Treatment: A Case Report
Ayyappan V Nair1, B Sai Theja2, J Sreejith Thampy2
1Department of Orthopaedics, Bengaluru Shoulder Institute, Bengaluru, Karnataka, India.
Multiple-site osteonecrosis (MSON) is a rare condition often linked to corticosteroid use. This case study shows core decompression, bone marrow aspirate concentrate, and alendronate can slow MSON progression, with tensor fascia lata grafting effective for hip involvement.
Area of Science:
- Orthopedics
- Bone Biology
- Regenerative Medicine
Background:
- Osteonecrosis (ON) is bone cell death due to disrupted blood flow.
- Multiple-site osteonecrosis (MSON) affects ≥3 anatomic sites, often linked to high-dose corticosteroid use.
- Management of ON in young adults is debated, with core decompression (CD) effective for early stages (Ficat I-II).
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
COPD: Management Using Bronchodilators and Corticosteroids
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
